We examined the performance of sFlt-1, PlGF and the sFlt-1:PlGF ratio at 36 weeks’ gestation in the identification of women who subsequently gave birth to a SGA infant, or who developed preeclampsia. The gene discussed is PGF; the disease is preeclampsia.